80:oral Is there something special about rare diseases? Examining societal preferences for exempting orphan drugs from cost-effectiveness criteria for reimbursement

80:oral Is there something special about rare diseases? Examining societal preferences for exempting orphan drugs from cost-effectiveness criteria for reimbursement

Bibliographic Details
Main Authors:	Werner Brouwer, Lucas Goossens, Vivian Reckers-Droog, Job van Exel
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-04-01
Series:	BMJ Global Health

Similar Items

Who should receive treatment? An empirical enquiry into the relationship between societal views and preferences concerning healthcare priority setting.
by: Vivian Reckers-Droog, et al.
Published: (2018-01-01)

Methodological choices in applications of Q methodology: A systematic literature review
by: Charlotte M. Dieteren, et al.
Published: (2023-01-01)

Viewpoints among experts and the public in the Netherlands on including a lifestyle criterion in the healthcare priority setting
by: Charlotte M. Dieteren, et al.
Published: (2022-02-01)

Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations.
by: Vivian Reckers-Droog, et al.
Published: (2020-01-01)

Pricing and reimbursement of orphan drugs: the need for more transparency
by: Simoens Steven
Published: (2011-06-01)

Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
by: Hans-Georg Eichler, et al.
Published: (2023-01-01)

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
by: Ewa Stawowczyk, et al.
Published: (2019-11-01)

Trends in individual reimbursement of orphan drugs in Latvia in 2008–2011
by: Logviss K., et al.
Published: (2014-01-01)

A systematic review of moral reasons on orphan drug reimbursement
by: Bettina M. Zimmermann, et al.
Published: (2021-06-01)

Societal preferences for funding orphan drugs in China: An application of the discrete choice experiment method
by: Shuoyuan Tan, et al.
Published: (2022-12-01)

Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
by: Szczepan Jakubowski, et al.
Published: (2024-03-01)

Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison
by: Jong Hyuk Lee
Published: (2021-03-01)

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
by: Krzysztof Piotr Malinowski, et al.
Published: (2020-10-01)

New reimbursement criteria for lipid-lowering drugs
by: Mario Eandi
Published: (2011-06-01)

Compassionate use and hospital exemption for regenerative medicine: Something wrong to apply the program for patients in a real world
by: Kazuo Yano, et al.
Published: (2018-06-01)

A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries
by: Marcin Czech, et al.
Published: (2020-01-01)

Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis
by: Katarzyna Kolasa, et al.
Published: (2018-04-01)

Exemption of the seller under art. 80 of the UN Convention on Contracts for the International Sale of Goods
by: Fišer-Šobot Sandra
Published: (2013-01-01)

CRITERIA OF PROVING DIGITAL CRIMES WITH THE USE OF MOBILE APPLICATIONS. FEATURES OF EXEMPTION
by: M. S. Sergeyev
Published: (2016-06-01)

Impacts of adjustment of National Reimbursement Drug List on orphan drugs volume and spending in China: an interrupted time series analysis
by: Yu Xie, et al.
Published: (2023-10-01)

Exempt Information
by: Simpson, E, et al.
Published: (2009)

Religious Exemptions
by: Anne Zimmerman
Published: (2021-11-01)

Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
by: Andreja Detiček, et al.
Published: (2018-06-01)

How do combinations of unhealthy behaviors relate to attitudinal factors and subjective health among the adult population in the Netherlands?
by: Charlotte M. Dieteren, et al.
Published: (2020-04-01)

Something old, something new and something borrowed
by: Fox, K, et al.
Published: (2021)

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
by: Krzysztof Piotr Malinowski, et al.
Published: (2018-11-01)

Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria
by: Georgi Iskrov, et al.
Published: (2016-02-01)

Quality of life of nursing home residents with dementia: validation of the German version of the ICECAP-O.
by: Peter Makai, et al.
Published: (2014-01-01)

Content validation of the Well-being of Older People measure (WOOP)
by: Mariska Q. N. Hackert, et al.
Published: (2021-08-01)

Active pulmonary tuberculosis: something old, something new, something borrowed, something blue
by: Maria T. A. Wetscherek, et al.
Published: (2022-01-01)

Something Old, Something New, Something Borrowed, Something Taboo: Interaction and Creativity in Humour
by: Vladislav Maraev, et al.
Published: (2021-05-01)

Pesticide Tolerances and Exemptions
by: Mark A. Mossler, et al.
Published: (2006-04-01)

Inabilities, excuses and exemptions
by: David Botting
Published: (2015-08-01)

Exempt from Tribute
by: Joshua D. Sosin
Published: (2006-02-01)

Something old, something new
by: Rogério de Souza Farias
Published: (2017-10-01)

Something old, something new…
by: Glenn Matfin
Published: (2010-08-01)

Parental attitudes and perceptions associated with childhood vaccine exemptions in high-exemption schools.
by: Heidi L Pottinger, et al.
Published: (2018-01-01)

Something Old, Something New, Something Borrowed, Something Blue: Part 3 – An Elephant Never Forgets
by: Dougherty Mark
Published: (2017-07-01)

How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries
by: Alessandra Blonda, et al.
Published: (2022-07-01)

Editorial - Something Old, Something New
by: Terry Anderson
Published: (2004-08-01)